ES557801A0 - Procedimiento para ciclizar derivados 2,3-difenilicos de esteres-j-nitrilos - Google Patents

Procedimiento para ciclizar derivados 2,3-difenilicos de esteres-j-nitrilos

Info

Publication number
ES557801A0
ES557801A0 ES557801A ES557801A ES557801A0 ES 557801 A0 ES557801 A0 ES 557801A0 ES 557801 A ES557801 A ES 557801A ES 557801 A ES557801 A ES 557801A ES 557801 A0 ES557801 A0 ES 557801A0
Authority
ES
Spain
Prior art keywords
diphenilic
nitrils
cycling
esters
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557801A
Other languages
English (en)
Other versions
ES8802221A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Laboratoires Hoechst SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Hoechst SA filed Critical Laboratoires Hoechst SA
Publication of ES557801A0 publication Critical patent/ES557801A0/es
Publication of ES8802221A1 publication Critical patent/ES8802221A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES557801A 1985-04-04 1988-01-15 Procedimiento para ciclizar derivados 2,3-difenilicos de esteres-j-nitrilos Expired ES8802221A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8505123A FR2587339B1 (fr) 1985-04-04 1985-04-04 Nouveaux medicaments constitues par des derives-2,3 ou -3,4 diphenyles des esters g-nitriles ou leurs produits de cyclisation et procedes pour les preparer

Publications (2)

Publication Number Publication Date
ES557801A0 true ES557801A0 (es) 1988-04-16
ES8802221A1 ES8802221A1 (es) 1988-04-16

Family

ID=9317941

Family Applications (4)

Application Number Title Priority Date Filing Date
ES553642A Expired ES8802219A1 (es) 1985-04-04 1986-04-02 Procedimiento para ciclizar derivados 2,3-difenilicos de esteres de p-nitrilos.
ES557626A Expired ES8802491A1 (es) 1985-04-04 1987-07-16 Procedimiento para preparar nuevos derivados 3,4-difenilicos de esteres -8-nitrilos
ES557625A Expired ES8802490A1 (es) 1985-04-04 1987-07-16 Procedimiento para preparar nuevos derivados 2,3-difenilicos de esteres -8-nitrilos
ES557801A Expired ES8802221A1 (es) 1985-04-04 1988-01-15 Procedimiento para ciclizar derivados 2,3-difenilicos de esteres-j-nitrilos

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES553642A Expired ES8802219A1 (es) 1985-04-04 1986-04-02 Procedimiento para ciclizar derivados 2,3-difenilicos de esteres de p-nitrilos.
ES557626A Expired ES8802491A1 (es) 1985-04-04 1987-07-16 Procedimiento para preparar nuevos derivados 3,4-difenilicos de esteres -8-nitrilos
ES557625A Expired ES8802490A1 (es) 1985-04-04 1987-07-16 Procedimiento para preparar nuevos derivados 2,3-difenilicos de esteres -8-nitrilos

Country Status (11)

Country Link
US (1) US4785007A (es)
EP (1) EP0203308A2 (es)
JP (1) JPS61229854A (es)
KR (1) KR860008139A (es)
AU (1) AU5561786A (es)
DK (1) DK151586A (es)
ES (4) ES8802219A1 (es)
FR (1) FR2587339B1 (es)
GR (1) GR860891B (es)
PT (1) PT82333B (es)
ZA (1) ZA862458B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI875101A (fi) * 1986-12-03 1988-06-04 Tanabe Seiyaku Co Laktamderivat och preparat innehaollande dessa.
JP4943429B2 (ja) * 2005-07-22 2012-05-30 メルク・シャープ・エンド・ドーム・コーポレイション カリウムチャネル阻害剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE765203C (de) * 1939-08-02 1953-06-01 Ig Farbenindustrie Ag Verfahren zur Herstellung von Piperidonen und Piperidinen
US3468893A (en) * 1966-03-14 1969-09-23 Ciba Geigy Corp 1-substituted-diphenyl-azacycloalkenes
US3956314A (en) * 1970-07-24 1976-05-11 U.C.B., Societe Anonyme Derivatives of 2-pyrrolidinone
US3814771A (en) * 1970-11-19 1974-06-04 T Shen 5-phenyl-2-piperidones and 5-phenyl-2-thiopiperidones
US3718743A (en) * 1970-11-19 1973-02-27 Merck & Co Inc 5-phenyl-2-piperidones and 5-phenyl-2-thiopiperidones in compositions and methods for treating pain, fever and inflammation
AU518986B2 (en) * 1977-10-11 1981-10-29 Takeda Chemical Industries Ltd. Lactams

Also Published As

Publication number Publication date
ZA862458B (en) 1986-11-26
DK151586D0 (da) 1986-04-03
DK151586A (da) 1986-10-05
ES553642A0 (es) 1988-04-16
EP0203308A2 (de) 1986-12-03
KR860008139A (ko) 1986-11-12
PT82333B (fr) 1988-04-07
FR2587339A1 (fr) 1987-03-20
FR2587339B1 (fr) 1988-08-05
GR860891B (en) 1986-08-04
ES8802221A1 (es) 1988-04-16
ES8802491A1 (es) 1988-07-01
PT82333A (fr) 1986-05-01
ES8802219A1 (es) 1988-04-16
AU5561786A (en) 1986-10-09
ES557626A0 (es) 1988-07-01
ES8802490A1 (es) 1988-07-01
JPS61229854A (ja) 1986-10-14
US4785007A (en) 1988-11-15
ES557625A0 (es) 1988-07-01

Similar Documents

Publication Publication Date Title
MX162864B (es) Procedimiento para la preparacion de 2,2,6,6-tetraalquil-4-piperidilaminas
ES554759A0 (es) Procedimiento para la obtencion de 1,3,5-triazintrionas
MX164766B (es) Procedimiento para la obtencion de derivados de cefem
ES556598A0 (es) Procedimiento para la preparacion de derivados de 13beta-alquil-milbemicina
ES556514A0 (es) Procedimiento para la preparacion de derivados de 2-oxi-4h-3, 1-benzoxazin-4-ona
ES551733A0 (es) Procedimiento para preparar derivados de (dihidro-4, 5-1h-imidazolil-2)-2-didrido-2,3-indol
ES555278A0 (es) Procedimiento para la obtencion de derivados de diclorociclopropilalquilhidroxialquil-azol
ES552143A0 (es) Procedimiento para la obtencion de derivados de hexosa acilados
ES557801A0 (es) Procedimiento para ciclizar derivados 2,3-difenilicos de esteres-j-nitrilos
ES549378A0 (es) Procedimiento para la preparacion de derivados de 1,3,4-tia-diazol
ES557503A0 (es) Procedimiento para la obtencion de derivados de piridazo-(1,2-a)(1,2)diacepina
ES552144A0 (es) Procedimiento para la obtencion de derivados de hexosa acilados
ES551777A0 (es) Procedimiento de preparacion de derivados de 3-hidroxi-3-fenilpiperidina
ES554339A0 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina
ES550070A0 (es) Procedimiento para la obtencion de 5-metoxi-2-(((4-metoxi- 3,5 dimetil-2-piridil)metil)sulfinil)bencimidazol)
ES549906A0 (es) Procedimiento para la preparacion de derivados de 1,4-dihi- dropiridina
ES549319A0 (es) Procedimiento de obtencion de 2,2-dibromo-3-nitrilo-propio- namida
ES540773A0 (es) Procedimiento de obtencion de derivados de 1,4-dihidropiri- dina
ES541884A0 (es) Procedimiento para la preparacion de derivados de 10-amino- tieno (3,2) (1,5) benzotiazepinas
ES548648A0 (es) Procedimiento de preparacion de derivados de 1-oxa-2-oxo-3, 8-diaza-spiro (4,5)-decano
ES543962A0 (es) Nuevos derivados de 1,3-ditiol-2-ilideno
ES552493A0 (es) Procedimiento para la obtencion de 4,4'-diisocianato-fenilbencileter
ES550885A0 (es) Procedimiento para la sintesis de 4,9-dihidro-4-(1-metil-4-piperidinilideno)-10-h-benzo (4,5) ciclohepta-(1,2-b) tiofeno-10-ona
ES557504A0 (es) Procedimiento para la obtencion de derivados de piridazo-(1,2-a)(1,2)diacepina
ES542417A0 (es) Procedimiento para la obtencion de derivados de 2,6-dihalo- benzoilo.